Deal Type Classification
Deal Type describes the general scope of the deal pertaining to the asset. Major
categories include Mergers and Acquisitions, Partnerships and Asset Purchases. Subcategories
allow further classifications as they may be applicable to the asset. For example,
a pharmaceutical product asset may be dealt in a development and commercialization
M&A deals are located in the separate M&A section accessible from the top of the section header.
Mergers & Acquisitions
Acquisition in which 100% of the company is acquired
Acquisition in which 51-99% of the company is acquired
An option to acquire the company in the future based on pre-negotiated terms
Two companies merge to form a new company, with a new name
A private company acquires a publicly listed company, resulting in a new company
with a new name and symbol
Development and Commercialization License
License granted by one company (licensor) to another company (licensee) to make,
use or sell a product or technology. License deals involving an academic institution,
foundation or governmental organization are classified under Academic/Foundational/Govt.
Collaborative Research and Product License Option
A period of research conducted and funded by the partners with one company having
the option to license the product or technology after a pre-negotiated milestone
Equity Stake and License Option
A company purchases an equity stake in another company in exchange for an option
to license the product or technology after a pre-negotiated milestone. There is
no collaboration between the companies before the option in exercised.
Product License Option
A company has the option to license the product or technology after a pre-negotiated
milestone. There is no collaboration between the companies before the option in
Research and Development Only
Two or more companies will conduct research on the product or technology prior to
their licensing. Research and Development deals involving an academic institution, foundation
or governmental organization are classified under Academic/Foundational/Govt. Research.
Two or more companies form a separate entity to develop a product or technology
Sales, Marketing, and Co-Promotion
License granted by one company (licensor) to another company (licensee) solely to
sell, market or co-promote a product. Deals involving clinical development are classified
under Development and Commercialization License.
Two or more companies exchange rights to develop, commercialize or promote each
other's products or technologies
Research and license deals involving an academic institution, foundation or governmental
Other Unspecified Partnership
Partnerships that cannot be classified under any other partnership category above
Business Unit or Division Purchase
Purchase of an entire business unit or division. The seller has no obligation to
support the business unit or division unless pre-negotiated in the sale.
Purchase of a research, development or manufacturing facility
Product, Pipeline or Platform Purchase
Purchase of all rights to a single pharmaceutical product, a pharmaceutical product pipeline or a technology platform. The seller has no obligation to support the development or commercialization
of the product unless pre-negotiated in the sale.
Royalty Stream Monetization
Purchase of the right to receive financial consideration generated by the sales
of a product
Other Unspecified Asset Purchase
Purchase of all rights to equipment, data and IP or substantially all assets of a company. The seller has no obligation to support the development or commercialization of the asset unless pre-negotiated in the sale.
Contract R&D and Manufacturing Service
Contract research, development or manufacturing services provided by one company
for another. This includes services provided by contract research organizations
(CROs) and contract manufacturing organizations (CMOs). The company providing the
service does not have any rights to the resulting product unless pre-negotiated
in the contract.
Government Supply Contract
An agreement between a governmental organization and accompany for the supply of
pharmaceutical products. This includes vaccine stockpiles.
Spin-Out and Company Formation
A company or institution spinning out a technology, single product, product pipeline
or business unit into a newly formed, standalone company
Settlement Resulting in a License
A legal agreement that results in one company gaining a license to a disputed product
Pricing / Payor Agreement
An agreement between a drug development company and payor organization on the pricing
and reimbursement of a drug